1932-6203
OA
DOAJ
PLoS ONE
Public Library of Science · United States
- APC
- $2,477
- Time to publish
- 29 weeks
- Articles/yr
- 344,111
Subscription
Active
New discovery.
New discovery (Hong Kong. Online)
ISSN-L 2957-6946 · 2957-9422（other medium）
China · 2022
Submission → publication—
APC—
DOAJ—
Earliest year2022
Value profile v0.1
Topics
Computational Drug Discovery Methods9%
MicroRNA in disease regulation4%
Medicinal Plant Extracts Effects4%
Spinal Cord Injury Research4%
Retinal Diseases and Treatments4%
Neuroinflammation and Neurodegeneration Mechanisms4%
Intracerebral and Subarachnoid Hemorrhage Research4%
Growth Hormone and Insulin-like Growth Factors2%
Academic impact
- Cited at least once
- 29%
- Top 10% share of citations
- 50%
- Median citations
- 0
Influential citation share
- Influential citation share
- 0%
Semantic Scholar · 55 DOI
Originality (citation structure)
- References shared with peer papers
- 3%
- Self-journal citations
- 0%
Structural proxies from reference lists of sampled papers; not a verdict on originality.
Integrity
Retracted: 0
Most cited works
- Exploring the key mechanism of puerarin in treating stomach tumors based on network pharmacology 2024 · 3 cites
- Research advances in insulin-like growth factor 2024 · 2 cites
- Study on the mechanism of Lily in the treatment of viral pneumonia based on network pharmacology analysis 2023 · 2 cites
- The establishment of organoids and their applications 2025 · 1 cites
- The mechanism and treatment of myofascial pain syndrome 2025 · 1 cites
Most recent works
- Network pharmacology reveals the potential molecular mechanisms of Polygonatum sibiricum in the treatment of sleep disorders 2026 · 0 cites
- The bidirectional link between sleep disorders and cardio-cerebrovascular diseases 2026 · 0 cites
- Research progress on skin symptoms in patients with diabetes mellitus 2026 · 0 cites
- The establishment of organoids and their applications 2025 · 1 cites
- The mechanism and treatment of myofascial pain syndrome 2025 · 1 cites
Based on 56 works from OpenAlex (CC0) · method v0.1
Basic information
- Publisher
- — · China
- Country/Region
- China
- Subject
- Biochemistry, Genetics and Molecular Biology
- Open access
- —
- DOAJ
- —
- License
- —
- Earliest year
- 2022
- DOAJ article records
- —
- Journal website
- http://www.new-discovery.org.cn
- Verify this journal
-
ISSN Portal ↗ ·
Master Journal List ↗
✓ ISSN checksum valid - Submission page
- —
Reference data How to read journal metrics →
Articles/yr79
h-index2
2-yr mean citedness0.23
Last publication year2025
DOAJ article records—
Open access—
“2-yr mean citedness” is the OpenAlex field summary_stats.2yr_mean_citedness (CC0): mean citations per paper over a two-year window. It is a raw bibliometric field, not a journal rating, and is not used for default ranking.
Correct a record · Request removal
Subject classification
Pharmacology, Toxicology and Pharmaceutics14
Medicine11
Biochemistry, Genetics and Molecular Biology9
Neuroscience6
§
More →
Journals in the same subject
2045-2322
OA
DOAJ
Scientific Reports
Nature Portfolio · United Kingdom
- APC
- $2,850
- Time to publish
- 20 weeks
- Articles/yr
- 320,539
0021-9258
OA
DOAJ
Journal of Biological Chemistry
Elsevier BV · United States
- APC
- $3,430
- Time to publish
- 22 weeks
- Articles/yr
- 213,749
0027-8424
Proceedings of the National Academy of Sciences
National Academy of Sciences · United States
- APC
- —
- Time to publish
- —
- Articles/yr
- 173,124
0006-291X
Biochemical and Biophysical Research Communications
Elsevier BV · United States
- APC
- $3,110
- Time to publish
- —
- Articles/yr
- 101,536
2041-1723
OA
DOAJ
Nature Communications
Nature Portfolio · United Kingdom
- APC
- $7,350
- Time to publish
- 28 weeks
- Articles/yr
- 94,090